March 9, 2022 – Poor heart health, especially among women of color, puts both mothers-to-be and their infants at risk, with heart disease causing more than one in four pregnancy-related deaths (26.5%) in the U.S., according to the American Heart Association Heart Disease and Stroke Statistics 2022 U

March 9, 2022 — Medtronic is recalling (correcting) the TurboHawk Plus Directional Atherectomy System due to design similarities shared with another device that was 

March 9, 2022 – Point-of-care screening for atrial fibrillation (A-fib) using a new generation of handheld electrocardiogram (ECG) devices increased the rate of diagnosis in patients 85 and older, but failed to show similar results in those 65 and older, a study by Massachusetts General Hospital (MGH) has found.

March 9, 2022 – According to the American Heart Association, scientific research supports the view that losing an hour of much needed sleep may not be the only thing to dread about “springing forward” when clocks move up for daylight saving time later this month. The upcoming time change may also negatively impact your heart and brain health.


The University of Maryland Medical Center has announced that David Bennett, the 57-year old patient with terminal heart disease who made history as the first person to receive a genetically modified pig’s heart, passed away yeste


March 9, 2022 — Fujifilm Sonosite, Inc., a world leader in point-of-care ultrasound (POCUS) solutions today announced it has filed a patent infringement lawsuit against Butterfly Network in the United States District Court for the District of Delaware.

March 8, 2022 – Vitals Xchange is a cloud-based healthcare software that seamlessly connects with PointClickCare’s full-continuum platform which utilizes Emergency Medical Records (EMR) technology to streamline patient data transmission and analysis for various healthcare facilities.

March 8, 2022 – MemorialCare Heart & Vascular Institute (MHVI), through its advanced research program, is participating in a CSL Behring-sponsored multi-center, Phase III clinical trial – "ApoA-I Event reducinG in Ischemic Syndromes II (AEGIS-II) – which is studying the removal of cholesterol from the arteries to reduce the risk of a second heart attack or stroke in patients.

Mrach 8, 2022 – Diagnosing heart attacks after heart surgery remains difficult due to shortcomings of current diagnostic tools when applied to postoperative patients, including the electrocardiogram and blood tests to detect levels of cardiac troponins, according to an editorial in the New England Journal of Medicine (NEJM) written by two UT Southwestern faculty members.

March 7, 2022 — AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer. President and CEO Scott Whitaker released the following tribute:

Subscribe Now